Literature DB >> 28292492

Quality Control Process for EQ-5D-5L Valuation Studies.

Juan M Ramos-Goñi1, Mark Oppe2, Bernhard Slaap2, Jan J V Busschbach3, Elly Stolk4.   

Abstract

BACKGROUND: The values of the five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) are elicited using composite time trade-off and discrete choice experiments. Unfortunately, data quality issues and interviewer effects were observed in the first few EQ-5D-5L valuation studies. To prevent these issues from occurring in later studies, the EuroQol Group established a cyclic quality control (QC) process.
OBJECTIVES: To describe this QC process and show its impact on data quality.
METHODS: A newly developed QC tool provided information about protocol compliance, interviewer effects, and mean values by health state severity. In a cyclic process, this information is initially used to evaluate whether new interviewers meet minimal quality requirements and later to provide feedback about how their performance may be improved. To investigate the impact of this cyclic process, we compared the quality of the data in Dutch and Spanish valuation studies that did not have this QC process with that in the follow-up studies in the same countries that used the QC process. Data quality was measured using protocol violations, variability between interviewers, the proportion of inconsistent responders, and clustering of composite time trade-off values.
RESULTS: In Spain, protocol violations were reduced from 87% in the valuation study to 5% in the follow-up study and in the Netherlands from 20% to 8%. In both countries, interviewers performed more homogeneously in the follow-up studies. The number of inconsistent respondents was reduced by 23.2% in Spain and 23.6% in the Netherlands. Values were less clustered in the follow-up studies.
CONCLUSIONS: The implementation of a strict QC process in EQ-5D-5L valuation studies increases interviewer protocol compliance and promotes data quality.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Keywords:  economic; health status index; life valuation; quality control; quality of life

Mesh:

Year:  2016        PMID: 28292492     DOI: 10.1016/j.jval.2016.10.012

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  45 in total

1.  EQ-5D-5L Valuation for the Malaysian Population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo; Kim Rand-Hendriksen; Faridah Aryani Md Yusof
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

2.  A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Authors:  Pedro L Ferreira; Patrícia Antunes; Lara N Ferreira; Luís N Pereira; Juan M Ramos-Goñi
Journal:  Qual Life Res       Date:  2019-06-14       Impact factor: 4.147

3.  Maternal tobacco exposure and health-related quality of life during pregnancy: a national-based study of pregnant women in China.

Authors:  Weiwei Sun; Xinyu Huang; Huailiang Wu; Casper J P Zhang; Zongzhi Yin; Qianqian Fan; Huiyun Wang; Pallavi Jayavanth; Babatunde Akinwunmi; Yanxin Wu; Zilian Wang; Wai-Kit Ming
Journal:  Health Qual Life Outcomes       Date:  2021-05-20       Impact factor: 3.186

4.  Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.

Authors:  Richard Huan Xu; Dong Dong; Nan Luo; Eliza Lai-Yi Wong; Yushan Wu; Siyue Yu; Renchi Yang; Junshuai Liu; Huiqin Yuan; Shuyang Zhang
Journal:  Eur J Health Econ       Date:  2021-03-24

5.  EQ-5D-5L: a value set for Romania.

Authors:  Elena Olariu; Wael Mohammed; Yemi Oluboyede; Raluca Caplescu; Ileana Gabriela Niculescu-Aron; Marian Sorin Paveliu; Luke Vale
Journal:  Eur J Health Econ       Date:  2022-06-10

6.  Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia.

Authors:  Richard Huan Xu; Dong Dong; Nan Luo; Eliza Lai-Yi Wong; Renchi Yang; Junshuai Liu; Huiqin Yuan; Shuyang Zhang
Journal:  Qual Life Res       Date:  2021-11-30       Impact factor: 4.147

7.  Health state utilities for beta-thalassemia: a time trade-off study.

Authors:  Antony P Martin; Enrico Ferri Grazzi; Claudia Mighiu; Manoj Chevli; Farrukh Shah; Louise Maher; Anum Shaikh; Aliah Sagar; Hayley Hubberstey; Bethany Franks; Juan M Ramos-Goñi; Mark Oppe; Derek Tang
Journal:  Eur J Health Econ       Date:  2022-03-26

8.  A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.

Authors:  Donna Rowen; Clara Mukuria; Emily McDool
Journal:  Pharmacoeconomics       Date:  2022-07-13       Impact factor: 4.558

9.  Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan.

Authors:  Takeru Shiroiwa; Shunya Ikeda; Shinichi Noto; Takashi Fukuda; Elly Stolk
Journal:  Med Decis Making       Date:  2021-03-23       Impact factor: 2.583

10.  Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis).

Authors:  Marcel F Jonker; Richard Norman
Journal:  Health Econ       Date:  2021-11-28       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.